ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Federal Court Rules In Favor Of Boston Scientific In J&J Patent Case

DOW JONES NEWSWIRES A federal court ruled a stent system made by Boston Scientific Corp. (BSX) doesn't infringe on Johnson & Johnson (JNJ) patents, a judgment that helps the medical-device maker notch a win in a patent war with the health-care products giant. Johnson & Johnson had alleged in a 2008 suit that Boston Scientific's Promus everolimus-eluting coronary stent system infringed on two of its patents. Boston Scientific on Monday touted a decision from a federal court in New Jersey, saying the court had found the patents to be invalid. "Boston Scientific will continue to vigorously defend against any claims of infringement," said Tim Pratt, general counsel for the company. A spokeswoman for Johnson & Johnson couldn't immediately be reached for comment. The two companies have been locked in a long-running battle over intellectual property for heart stents, with both scoring some victories along the way. Johnson & Johnson shares were recently down slightly to $65.25 premarket, while Boston Scientific were up 1.2% to $6.05. -By Mia Lamar, Dow Jones Newswires; 212-416-3207;

Stock News for Boston Scientific (BSX)
10/05/201516:11:28Statement of Changes in Beneficial Ownership (4)
10/05/201516:06:37Current Report Filing (8-k)
10/05/201506:30:00Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable P...
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:23:21Statement of Changes in Beneficial Ownership (4)
10/01/201508:30:00Boston Scientific To Webcast Third Quarter 2015 Earnings Call...
09/29/201509:00:00Boston Scientific Launches The Captivator™ EMR Device To Treat D...
09/28/201507:00:00New Survey Reveals True Impact of Severe Asthma on People's Lives
09/28/201506:00:00Eluvia™ Drug-eluting Vascular Stent System Demonstrates 12-month P...
09/22/201508:45:00Technical Data on Healthcare Stocks - Infinity Pharmaceuticals...
09/18/201508:30:00Medical Appliances and Equipment Stocks Technical Report -- Boston...
09/10/201509:00:00Boston Scientific Announces CE Mark for the Vercise™ Primary C...
09/02/201508:30:00Boston Scientific To Participate In 2015 Morgan Stanley Global...
08/26/201508:30:00Boston Scientific To Participate In The 2015 Wells Fargo Healthcare...
08/24/201516:30:00Boston Scientific Announces CE Mark For MRI Compatible Labeling...
08/24/201516:07:02Statement of Changes in Beneficial Ownership (4)
08/20/201516:07:16Statement of Changes in Beneficial Ownership (4)
08/19/201516:45:00Boston Scientific Announces FDA Approval of Innova™ Vascular S...

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations